drugset / Trial / NCT04790734
Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Mechanically Ventilated ICU Patients
Phase 2
Completed
60 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of remimazolam compared to propofol for sedation in mechanically ventilated ICU patients.
Timeline
- Start
- 2021-05-10
- Primary completion
- 2022-04-12
- Completion
- 2022-05-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Propofol | Small molecule | 2 mg/kg | — |
| Subject | Remimazolam | Small molecule | 0.15 mg/kg | — |
Indications
No indication recorded.